PET-CT owns GE the fifth-generation Discovery STE16 PET/CT positron emission tomography, which can provide early diagnosis, location, staging, recurrence detection, treatment options, efficacy testing, PET/CT radiotherapy positioning, PET/CT biopsy, and a higher health examination.